These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 20723970

  • 1. The role of TFPI in regulation of TF-induced thrombogenicity on the surface of human monocytes.
    Basavaraj MG, Gruber FX, Sovershaev M, Appelbom HI, Osterud B, Petersen LC, Hansen JB.
    Thromb Res; 2010 Nov; 126(5):418-25. PubMed ID: 20723970
    [Abstract] [Full Text] [Related]

  • 2. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
    Paysant J, Soria C, Cornillet-Lefèbvre P, Nguyen P, Lenormand B, Mishal Z, Vannier JP, Vasse M.
    Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
    [Abstract] [Full Text] [Related]

  • 3. Coexpression of tissue factor and tissue factor pathway inhibitor by human monocytes purified by leukapheresis and elutriation. Response of nonadherent cells to lipopolysaccharide.
    Nguyên P, Broussas M, Cornillet-Lefèbvre P, Potron G.
    Transfusion; 1999 Sep; 39(9):975-82. PubMed ID: 10533824
    [Abstract] [Full Text] [Related]

  • 4. Circulating monocytes mirror the imbalance in TF and TFPI expression in carotid atherosclerotic plaques with lipid-rich and calcified morphology.
    Basavaraj MG, Sovershaev MA, Egorina EM, Gruber FX, Bogdanov VY, Fallon JT, Østerud B, Mathiesen EB, Hansen JB.
    Thromb Res; 2012 Apr; 129(4):e134-41. PubMed ID: 22178066
    [Abstract] [Full Text] [Related]

  • 5. Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1.
    Ott I, Andrassy M, Zieglgänsberger D, Geith S, Schömig A, Neumann FJ.
    Blood; 2001 Jun 15; 97(12):3721-6. PubMed ID: 11389008
    [Abstract] [Full Text] [Related]

  • 6. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
    Steppich BA, Seitz I, Busch G, Stein A, Ott I.
    Thromb Haemost; 2008 Dec 15; 100(6):1068-75. PubMed ID: 19132232
    [Abstract] [Full Text] [Related]

  • 7. Low thrombogenicity of calcified atherosclerotic plaques is associated with bone morphogenetic protein-2-dependent inhibition of tissue factor expression.
    Egorina EM, Sovershaev MA, Bogdanov VY, Sovershaev TA, Fallon JT, Seredkina N, Østerud B, Hansen JB.
    Blood Coagul Fibrinolysis; 2011 Dec 15; 22(8):642-50. PubMed ID: 21897206
    [Abstract] [Full Text] [Related]

  • 8. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM, Pepe G, Attanasio M, Falciani M, Abbate R, Prisco D, Fedi S, Giusti B, Brunelli T, Giusti B, Brunelli T, Comeglio P, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1999 Apr 15; 81(4):589-93. PubMed ID: 10235445
    [Abstract] [Full Text] [Related]

  • 9. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease.
    Kim HK, Song KS, Park YS, Yun YS, Shim WH.
    Cardiology; 2000 Apr 15; 93(1-2):31-6. PubMed ID: 10894904
    [Abstract] [Full Text] [Related]

  • 10. Fibronectin-adherent monocytes express tissue factor and tissue factor pathway inhibitor whereas endotoxin-stimulated monocytes primarily express tissue factor: physiologic and pathologic implications.
    Bajaj MS, Ghosh M, Bajaj SP.
    J Thromb Haemost; 2007 Jul 15; 5(7):1493-9. PubMed ID: 17470199
    [Abstract] [Full Text] [Related]

  • 11. Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium.
    Grabowski EF, Kushak RI, Liu B, Ingelfinger JR.
    Thromb Res; 2013 Jun 15; 131(6):521-8. PubMed ID: 23642803
    [Abstract] [Full Text] [Related]

  • 12. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
    Bohgaki M, Atsumi T, Yamashita Y, Yasuda S, Sakai Y, Furusaki A, Bohgaki T, Amengual O, Amasaki Y, Koike T.
    Int Immunol; 2004 Nov 15; 16(11):1633-41. PubMed ID: 15466912
    [Abstract] [Full Text] [Related]

  • 13. Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis.
    Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K.
    J Pathol; 1999 Jun 15; 188(2):180-8. PubMed ID: 10398162
    [Abstract] [Full Text] [Related]

  • 14. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions. On behalf of the Subcommittee on Tissue factor Pathway Inhibitor (TFPI) of the Scientific and Standardization Committee of the ISTH.
    Osterud B, Bajaj MS, Bajaj SP.
    Thromb Haemost; 1995 May 15; 73(5):873-5. PubMed ID: 7482419
    [Abstract] [Full Text] [Related]

  • 15. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation.
    Zillmann A, Luther T, Müller I, Kotzsch M, Spannagl M, Kauke T, Oelschlägel U, Zahler S, Engelmann B.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):603-9. PubMed ID: 11181090
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
    Petit L, Lesnik P, Dachet C, Moreau M, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 1999 Feb 23; 19(2):309-15. PubMed ID: 9974412
    [Abstract] [Full Text] [Related]

  • 17. Bone morphogenetic protein -7 increases thrombogenicity of lipid-rich atherosclerotic plaques via activation of tissue factor.
    Sovershaev MA, Egorina EM, Bogdanov VY, Seredkina N, Fallon JT, Valkov AY, Østerud B, Hansen JB.
    Thromb Res; 2010 Oct 23; 126(4):306-10. PubMed ID: 20656331
    [Abstract] [Full Text] [Related]

  • 18. Oncostatin M induces procoagulant activity in human vascular smooth muscle cells by modulating the balance between tissue factor and tissue factor pathway inhibitor.
    Mirshahi F, Vasse M, Tedgui A, Li H, Merval R, Legrand E, Vannier JP, Soria J, Soria C.
    Blood Coagul Fibrinolysis; 2002 Jul 23; 13(5):449-55. PubMed ID: 12138373
    [Abstract] [Full Text] [Related]

  • 19. Production of tissue factor pathway inhibitor in cardiomyocytes and its upregulation by interleukin-1.
    Kereveur A, Enjyoji K, Masuda K, Yutani C, Kato H.
    Thromb Haemost; 2001 Nov 23; 86(5):1314-9. PubMed ID: 11816723
    [Abstract] [Full Text] [Related]

  • 20. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar 23; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.